[HTML][HTML] Clinically relevant prognostic and predictive markers for immune-checkpoint-inhibitor (ICI) therapy in non-small cell lung cancer (NSCLC)
WM Brueckl, JH Ficker, G Zeitler - BMC cancer, 2020 - Springer
Background Immune checkpoint inhibitors (ICI) either alone or in combination with
chemotherapy have expanded our choice of agents for the palliative treatment of non-small …
chemotherapy have expanded our choice of agents for the palliative treatment of non-small …
Clinically relevant prognostic and predictive markers for immune-checkpoint-inhibitor (ICI) therapy in non-small cell lung cancer (NSCLC)
WM Brueckl, JH Ficker, G Zeitler - BMC Cancer, 2020 - search.proquest.com
Background Immune checkpoint inhibitors (ICI) either alone or in combination with
chemotherapy have expanded our choice of agents for the palliative treatment of non-small …
chemotherapy have expanded our choice of agents for the palliative treatment of non-small …
[PDF][PDF] Clinically relevant prognostic and predictive markers for immune-checkpoint-inhibitor (ICI) therapy in non-small cell lung cancer (NSCLC)
WM Brueckl, JH Ficker, G Zeitler - 2020 - scholar.archive.org
Background: Immune checkpoint inhibitors (ICI) either alone or in combination with
chemotherapy have expanded our choice of agents for the palliative treatment of non-small …
chemotherapy have expanded our choice of agents for the palliative treatment of non-small …
Clinically relevant prognostic and predictive markers for immune-checkpoint-inhibitor (ICI) therapy in non-small cell lung cancer (NSCLC).
WM Brueckl, JH Ficker, G Zeitler - BMC Cancer, 2020 - go.gale.com
Background Immune checkpoint inhibitors (ICI) either alone or in combination with
chemotherapy have expanded our choice of agents for the palliative treatment of non-small …
chemotherapy have expanded our choice of agents for the palliative treatment of non-small …
Clinically relevant prognostic and predictive markers for immune-checkpoint-inhibitor (ICI) therapy in non-small cell lung cancer (NSCLC).
WM Brueckl, JH Ficker, G Zeitler - BMC Cancer, 2020 - europepmc.org
Background Immune checkpoint inhibitors (ICI) either alone or in combination with
chemotherapy have expanded our choice of agents for the palliative treatment of non-small …
chemotherapy have expanded our choice of agents for the palliative treatment of non-small …
Clinically relevant prognostic and predictive markers for immune-checkpoint-inhibitor (ICI) therapy in non-small cell lung cancer (NSCLC)
WM Brueckl, JH Ficker, G Zeitler - BMC cancer, 2020 - pubmed.ncbi.nlm.nih.gov
Background Immune checkpoint inhibitors (ICI) either alone or in combination with
chemotherapy have expanded our choice of agents for the palliative treatment of non-small …
chemotherapy have expanded our choice of agents for the palliative treatment of non-small …
[HTML][HTML] Clinically relevant prognostic and predictive markers for immune-checkpoint-inhibitor (ICI) therapy in non-small cell lung cancer (NSCLC)
WM Brueckl, JH Ficker, G Zeitler - BMC Cancer, 2020 - bmccancer.biomedcentral.com
Immune checkpoint inhibitors (ICI) either alone or in combination with chemotherapy have
expanded our choice of agents for the palliative treatment of non-small cell lung cancer …
expanded our choice of agents for the palliative treatment of non-small cell lung cancer …
[引用][C] Clinically relevant prognostic and predictive markers for immune-checkpoint-inhibitor (ICI) therapy in non-small cell lung cancer (NSCLC)
WM Brueckl, JH Ficker, G Zeitler - BMC Cancer (Web), 2020 - jglobal.jst.go.jp
Clinically relevant prognostic and predictive markers for immune-checkpoint-inhibitor (ICI)
therapy in non-small cell lung cancer (NSCLC) | Article Information | J-GLOBAL Art J-GLOBAL …
therapy in non-small cell lung cancer (NSCLC) | Article Information | J-GLOBAL Art J-GLOBAL …
[HTML][HTML] Clinically relevant prognostic and predictive markers for immune-checkpoint-inhibitor (ICI) therapy in non-small cell lung cancer (NSCLC)
WM Brueckl, JH Ficker, G Zeitler - BMC Cancer, 2020 - ncbi.nlm.nih.gov
Background Immune checkpoint inhibitors (ICI) either alone or in combination with
chemotherapy have expanded our choice of agents for the palliative treatment of non-small …
chemotherapy have expanded our choice of agents for the palliative treatment of non-small …
Clinically relevant prognostic and predictive markers for immune-checkpoint-inhibitor (ICI) therapy in non-small cell lung cancer (NSCLC)
WM Brueckl, JH Ficker, G Zeitler - BMC Cancer, 2020 - cir.nii.ac.jp
抄録< jats: title> Abstract</jats: title>< jats: sec>< jats: title> Background</jats: title>< jats: p>
Immune checkpoint inhibitors (ICI) either alone or in combination with chemotherapy have …
Immune checkpoint inhibitors (ICI) either alone or in combination with chemotherapy have …